SuperGen, Inc. to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 8th

DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at Biotechnology Industry Organization’s CEO & Investor Conference on Monday, February 8th in New York.
MORE ON THIS TOPIC